Cephalon, Inc.
Quick facts
Marketed products
- Liposomal doxorubicin hydrochloride · Oncology
Phase 2 pipeline
- Free doxorubicin hydrochloride · Oncology
Doxorubicin hydrochloride intercalates DNA and inhibits topoisomerase II, leading to DNA damage and cell death.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Cephalon, Inc.
What are Cephalon, Inc.'s marketed drugs?
Top marketed products include Liposomal doxorubicin hydrochloride.
Related
- Liposomal doxorubicin hydrochloride · Oncology
- Sector hub: All tracked pharma companies